Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne blaIMP-1 in a Tertiary

Ana Carolina Ramos1, Rodrigo Cayô2, Cecilia Godoy Carvalhaes3

  • 1Universidade Federal de São Paulo (UNIFESP), Laboratório Alerta, Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina (EPM), São Paulo, Brazil anarolramos@msn.com.

Insights

Multidrug-resistant Proteus mirabilis clones carrying novel carbapenemase genes pose a significant threat. These bacteria are resistant to key antibiotics, complicating treatment and infection control efforts.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • The emergence of multidrug-resistant bacteria, particularly Proteus mirabilis, is a growing global health concern.
  • Carbapenemase-producing Enterobacteriaceae (CPE) present a critical challenge due to limited treatment options.
  • Integrons and plasmids are key mobile genetic elements facilitating the spread of antibiotic resistance genes.

Purpose of the Study:

  • To characterize multidrug-resistant Proteus mirabilis clones harboring a novel class 1 integron.
  • To investigate the genetic environment of the blaIMP-1 gene within these resistant clones.
  • To identify the co-occurrence of other resistance genes on mobile genetic elements.

Main Methods:

  • Whole-genome sequencing of Proteus mirabilis isolates.
  • Plasmid analysis and characterization.
  • Integron and gene cassette analysis.

Main Results:

  • Identification of multidrug-resistant Proteus mirabilis clones.
  • Characterization of a novel class 1 integron, In1359, carrying the blaIMP-1 gene.
  • The integron was located on a large conjugative plasmid that also harbored the blaCTX-M-2 gene.
  • The identified clones exhibited intrinsic resistance to polymyxins and tigecycline.

Conclusions:

  • The findings highlight the emergence of Proteus mirabilis clones with a concerning resistance profile.
  • The co-location of blaIMP-1 and blaCTX-M-2 on a conjugative plasmid facilitates the rapid dissemination of carbapenem and extended-spectrum beta-lactamase resistance.
  • These multidrug-resistant strains represent a serious challenge for clinical management and infection control strategies.